Min Su Peter Kang
@KangMSPeter
Followers
267
Following
2K
Media
26
Statuses
762
Joined August 2013
💥New connectomics paper, now out in @braincomms We show that indirect “multi-step” connectivity changes to the entorhinal cortex in #Alzheimers unfold along the major axes of 🧠 organization, aka the connectome gradients🌈 ➡️ https://t.co/GeF0K90rC2
1
2
8
🔥Recent advances in #neuroimaging of #Alzheimers disease🧠✨ https://t.co/BrKZqeFjTY ➡️ Resource for researchers & clinicians ➡️ ATNIV biomarkers, staging, connectomics &more ➡️ Plus: how are sex & country represented in first/last authorship? @NeuroimagingPIA
@alzdemjournals
0
9
20
It’s an incredible honour to receive the #AAIC25 @ISTAART postdoctoral poster competition award! Thank you to all the judges and @alzassociation for highlighting our work, as well as @Sunnybrook, @CIHR_IRSC, @AlzCanada, my team and colleagues for their support ❤️
Congratulations to our #AAIC25 @ISTAART student and postdoctural poster competition winners! 🔬 @FernandaBAragao 🔬 @kangmspeter 🔬 @lidia_vaque 🔬 Tae Yeon Kim 🔬 Lara Huyghe 🔬 Eden Mancor
1
1
16
In our paper, published today in EJNM, we introduce a technique to profile tau tangle accumulation in the brain across the Alzheimer's disease (AD) spectrum: https://t.co/EXvUq6OxHF 1/5
link.springer.com
European Journal of Nuclear Medicine and Molecular Imaging - Inter-individual variability in tau topography challenges the propagation hypothesis of tau aggregates. To address this gap, we propose...
1
11
28
January is #AlzheimersAwarenessMonth. With no cure for the disease, scientists like Dr. Julie Ottoy, are conducting research that is leading to breakthroughs in the diagnosis, progression and prevention of Alzheimer’s. Read more about her work: https://t.co/wztrhGsd7U
0
3
14
If you are interested in #microglia 🧠🎇, check out the new book 📗, elegantly edited by Drs. Tremblay and Verkhratsky!! We wrote an exciting chapter on glial imaging - with the amazing @LiviaDePicker @KangMSPeter chapter: https://t.co/9lF6pU7sQb book:
link.springer.com
Microglia, the resident immune cells of the central nervous system (CNS) play a key role in regulating and maintaining homeostasis in the brain. However, the CNS is also vulnerable to infections and...
0
4
23
Poor physical health is associated with depression. Yes, we know. But how so? Our new study @NatMentHealth reveals integrated pathways that explain the interplay between brain, body, lifestyle and their collective influence on mental health. https://t.co/q2bNr4QVBY 🧵1/7
5
83
206
Thank you @_BrightFocus for your amazing support! Looking forward to working together ☺️
📣 Meet our newest grant recipients across Alzheimer’s disease, macular degeneration, and glaucoma research! These 44 exceptional investigators, selected for their potential to bring us closer to cures by pursuing the untried, the unexpected, and the most promising ideas,
0
1
16
10 years ago, we sat next to each other measuring proteins and looking at brain tissues at the @Imaging_AD wet lab. Today, @erzimmer is recognized for his brilliance and dedication by #AAIC2024, the largest #AD research community! Biggest congrats 👏🎉🧠
Congratulations to @erzimmer, the #AAIC24 recipient of the Blas Frangione Early Career Achievement Award. This award recognizes early career researchers whose research in Alzheimer’s & dementia has the potential to impact the field by propelling it in novel directions.
1
1
11
🔥Years in the making, now published! My final postdoc project in @NatureComms shows that Tau and TSPO PET follow gradients🌈 of connectivity in #Alzheimer disease 🧠 https://t.co/Mm2elGT5Fv Thanks to @alzassociation @Sunnybrook @MCSA_Montreal Now ready for new adventures!🌍☺️
nature.com
Nature Communications - In Alzheimer’s disease, the role of connectivity in facilitating pathology accumulation remains unclear. Using in-vivo neuroimaging, the authors show that tau and...
3
17
73
I will present the @NeuroimagingPIA year in review talk at ✨AIC 2024✨in Philadelphia this July!🤩 many thanks to @alzassociation #AAIC24 🎖️ Please help me compile the most inspiring papers of the year (including your own research!) via this survey: 📨
docs.google.com
Dear friends, colleagues, and members of the Neuroimaging PIA, I am incredibly honored and excited to be invited to give the opening plenary talk at the next Alzheimer’s Imaging Consortium (AIC) on...
1
15
41
The first cellular map of a mammalian brain is here. 🧠✨ Over 6 years and 32 million cells in the making, the complete adult mouse brain cell-type atlas reveals astonishing diversity and regional specificity. Dive deeper: https://t.co/CXEIXooOVu
@nature #studyBRAIN #BICCN
10
620
2K
⚠️Our lab at @UofT is recruiting a postdoc in AI! If you like living in a vibrant city 🌇 and work with talented people on exciting Neuroscience projects 🧠in neurodegenerative disease, then check out this ad: https://t.co/VS9S0buSS2— PIs: M. Goubran & S. Black ✨
0
5
14
Upcoming Workshop Series: Neuroimaging and Fluid Biomarkers of Neurodegenerative Disease Workshop Series run by Drs. @OttoyJulie, @MRuthirakuhan, @KangMSPeter, and Joel Rameriz from @Sunnybrook. More info and registration:
vast-training.org
This workshop on neuroimaging and fluid biomarkers of neurodegenerative disease will be led by Dr. Myuri Ruthirakuhan, Dr. Joel Ramirez, Dr. Julie Ottoy, and Dr. Min Su (Peter) Kang. The workshop...
0
3
6
Excited to present a keynote on vascular contributions to dementia this Thursday at 2PM 🩺🧠🩸. This will be followed by exciting talks from the VAST scholars on vascular injury and VCID. Register for this virtual event -info below! @VAST_training @A_Attarpour
This Thursday we are hosting our second annual VAST Summer Symposium! Join us in supporting our amazing cohort of summer scholars! More info here: https://t.co/JCaSdhpSLe
1
4
10
Now in @BrainBehavImm : the largest TSPO-PET meta-analysis to date 💥across 11 distinct neurological/neuropsychiatric illness categories 🧠 https://t.co/P6juitqHJf
@LiviaDePicker @KangMSPeter @BennoHaarman @IgorBranchi
1
13
38
FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval
fda.gov
The FDA converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval.
0
0
4
Congratulations to our eminent neuropsychologist Brenda Milner, who is the newest (and oldest) inductee to Canada's Walk of Fame!
Watch Dr. Brenda Milner react to her 2023 @CWOFame Induction! (Science, Technology & Innovation presented by @sanoficanada ) @TheNeuro_MNI
#CanadaThrives #CWOF25th
2
31
166
🔥 @_JCBFM thank you for featuring our work on your June issue cover! 🔥 We investigated free water and amyloid-PET of the white matter as in-vivo imaging markers of cerebrovascular injury in a mixed dementia cohort 🧠 https://t.co/5PwuU2q0ss
@Sunnybrook
0
5
23